首页> 美国卫生研究院文献>Critical Care >Pro/con clinical debate: Life support should have a special status among therapies and patients or their families should have a right to insist on this treatment even if it will not improve outcome
【2h】

Pro/con clinical debate: Life support should have a special status among therapies and patients or their families should have a right to insist on this treatment even if it will not improve outcome

机译:赞成/反对派临床辩论:生命支持应在治疗中具有特殊地位患者或其家人应有权坚持这种治疗即使这种治疗不能改善预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Most hospitals are facing the dilemma caused by demand for critical care beds outstripping supply. This imbalance is likely to get worse over the coming years as a result of many factors, including aging of the population, improved technology, and improved therapies, among other factors. As a result we are likely to have to make further tough decisions about rationing of this service. In this issue of Critical Care, two authors debate the appropriateness of providing life support in accordance with a family's wishes to an individual who is unlikely to survive admission to the intensive care unit. Understanding both sides of this debate is an important aspect of an intensivist's job.
机译:大多数医院都面临着重病床需求超过供应的困境。由于许多因素,包括人口老龄化,技术改进和疗法改善等,这种失衡在未来几年内可能会变得更加严重。结果,我们可能不得不就此服务的配给做出更艰难的决定。在本期《重症监护》中,两位作者讨论了根据家庭的意愿向不太可能在重症监护病房中幸存下来的个人提供生活支持的适当性。理解这场辩论的双方都是强化主义者工作的重要方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号